J. Andersen

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.

D. V. Von Hoff, M. Moore, E. Casper, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

D. V. Von Hoff, M. Moore, H. Burris, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Drug‐drug interaction between warfarin and statins: A Danish cohort study

A. Pottegård, F. Persson, C. Andersen, 2020, British journal of clinical pharmacology.

A Case Study of an Adaptive Clinical Trial in the Treatment of Out-Patients with Depressive Disorder

Douglas E. Faries, Roy N. Tamura, R. Tamura, 1994 .

Comparison of Azone and Hexamethylene Lauramide in Toxicologic Effects and Penetration Enhancement of Cimetidine in Rabbit Eyes

J. Andersen, D. Tang-Liu, I. Ismail, 1992, Pharmaceutical Research.

Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients

A. Rush, H. Roffwarg, D. Dunner, 1994, Psychiatry Research.

A randomized play-the-winner design for multi-arm clinical trials

D. Faries, John S. Andersen, J. Andersen, 1994 .

Enhancing the value delivered by the statistician throughout drug discovery and development: putting statistical science into regulated pharmaceutical innovation

G G Enas, J S Andersen, G. Enas, 2001, Statistics in medicine.

Use of predictive probabilities in phase II and phase III clinical trials.

J S Andersen, D Johns, J. Andersen, 1999, Journal of biopharmaceutical statistics.

Clinical trial designs--made to order.

J. Andersen, J S Andersen, 1996, Journal of biopharmaceutical statistics.